Consolidated Balance Sheets - (Parenthetical) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023
Cash and cash equivalents (VIE: $2,019 and $2,277 at January 31, 2023 and January 31, 2024, respectively)	$ 112,085	$ 82,036
Accounts receivable, less allowances of $899 and $1,451 at January 31, 2023 and January 31, 2024, respectively	1,451	899
Investments (related party $2,500 at January 31, 2023 and January 31, 2024)	$ 9,294	$ 6,531
Preferred stock, par value (in USD per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in USD per share)	$ 0.0005	$ 0.0005
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares, issued (in shares)	113,684,299	111,424,132
Common stock, shares outstanding (in shares)	113,684,299	111,424,132
Related Party
Investments (related party $2,500 at January 31, 2023 and January 31, 2024)	$ 2,500	$ 2,500
Variable Interest Entity, Primary Beneficiary
Cash and cash equivalents (VIE: $2,019 and $2,277 at January 31, 2023 and January 31, 2024, respectively)	$ 2,277	$ 2,019